Glucocorticoid-Induced Osteoporosis

Factors Associated with the Prevention of Glucocorticoid-Induced Osteoporosis using a Large U.S. National Pharmacy Database

Authors: Ryan Outman, University of Alabama at Birmingham, USA, Ronald Aubert, Medco Health Solutions, Inc., USA, Jeffrey Curtis, University of Alabama at Birmingham, USA, Robert Epstein, Medco Health Solutions, Inc., USA, Felix Frueh, Medco Health Solutions, Inc., USA, Mona Khalid, Medco Health Solutions, Inc., USA, Christopher Sanders, Medco Health Solutions, Inc., USA, Eric Stanek, Medco Health Solutions, Inc., USA, Amy Steinkellner, Medco Health Solutions, Inc., USA, Amy Warriner, University of Alabama At Birmingham, USA, Kenneth Saag, University of Alabama at Birmingham, USA

Treatment rates of glucocorticoid-induced osteoporosis remain low, especially among those under age 50.

Citation: ASBMR 2010 Annual Meeting; Poster Sessions; Presentation Number: SU0385; Session: Poster Session II & Poster Tours; Sunday, October 17, 2010 11:00 AM - 1:00 PM, Metro Toronto Convention Centre, South Building, South Building: Hall E

Link: http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=8ce86289-29ee-4659-b281-73b4a077f5af